Vitalex Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vitalex biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vitalex Biosciences Today - Breaking & Trending Today

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

Ashraf Ibrahim , Max Benavidez , Los Angeles , Vitalex Biosciences , Brevisrefero Corporation For Chemistry , Lundquist Institute , National Institute Of Allergy , Lundquist Institute For Biomedical Innovation , National Institutes Of Health , Good Laboratory Practice , National Institute , Infectious Diseases , National Institutes , Investigational New Drug , Brevisrefero Corporation , Benavidez The Lundquist Institute , Biomedical Innovation ,

Vaccine Trial Shows Promise Against Candida Fungal Infection

Although relatively rare, C. auris infections can lead to death for between 30% to 70% of those at higher risk. ....

Vitalex Biosciences , Ashraf Ibrahim , Lundquist Institute In Torrance , Lundquist Institute , Only Fungus , Possible Role , Candida Auri , C Aurirs , Fungal Infection , Vaccine Development ,

Lindquist investigator research on mucormycosis, the deadly 'black fungus'

Credit: The Lundquist Institute
LOS ANGELES (May 13, 2021) The Lundquist Institute today announced that one of its spinoff start-up companies, Vitalex Biosciences, founded by researcher Dr. Ashraf Ibrahim, is producing an antibody that stems the spread of mucormycosis, a deadly fungal infection with an overall mortality rate of 50% and higher. Mucormycosis is an emerging infection caused by exposure to mucor, a mold commonly found in soil, plants, manure, and decaying fruits and vegetables. It affects the sinuses, the brain and the lungs and is life-threatening in diabetic or severely immunocompromised individuals, such as cancer patients. In addition to the >50% death rates, extremely disfiguring surgery is often needed to remove necrotic tissues. ....

Vitalex Biosciences , Max Benavidez , Ashraf Ibrahim , Small Business Innovation Research , National Institute Of Allergy , Lundquist Institute , National Institute , Infectious Diseases , Medicine Health , Aids Hiv , Critical Care Emergency Medicine , Death Dying , Infectious Emerging Diseases , Public Health , Disease In The Developing World , அதிகபட்சம் பெனாவிடெஸ் , அஷ்ரஃப் இப்ராஹிம் , சிறிய வணிக கண்டுபிடிப்பு ஆராய்ச்சி , தேசிய நிறுவனம் ஆஃப் ஒவ்வாமை , லண்ட்கிஸ்ட் நிறுவனம் , தேசிய நிறுவனம் , தொற்று நோய்கள் ,